AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. SATO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Net income

SATO PHARMACEUTICAL CO.,LTD.【JP:E00954】

Market cap
P/E ratio
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndNet income (Million JPY)YoY (%)
Jul 31, 20231,965+164.47%
Jul 31, 2022743+35.83%
Jul 31, 2021547-71.01%
Jul 31, 20201,887-5.84%
Jul 31, 20192,004+135.21%
Jul 31, 2018852-340.00%
Jul 31, 2017-355+34.98%
Jul 31, 2016-263-122.75%
Jul 31, 20151,156-37.75%
Jul 31, 20141,857-24.54%
Jul 31, 20132,461+71.26%
Jul 31, 20121,437-1.17%
Jul 31, 20111,454

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)